Assessing the Impact of a Safe and Equitable Biosimilar Policy in the United States: Hearing Before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, First Session, May 2, 2007, Volume 4

Front Cover
U.S. Government Printing Office, Jan 1, 2008 - Biologicals - 184 pages
0 Reviews

From inside the book

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

Section 1
1
Section 2
5
Section 3
11
Copyright

10 other sections not shown

Other editions - View all

Common terms and phrases

Bibliographic information